The Problem We're Solving
PTSD care is uneven.
Medication side effects and adherence challenges limit outcomes, and clinic capacity can’t keep up with demand.
Health systems and payers want measurable outcomes, predictable costs, and models that scale without adding staff.
NeuroEmpathy is designed to deliver durable symptom reduction with higher clinic throughput and reviewer‑ready evidence.
The NeuroEmpathy Approach
A wearable neuroelectric therapy system built for real life.
NeuroEmpathy brings bioelectric medicine out of the clinic and into everyday environments.
The platform is a smart‑textile sleeve paired with subsensory microcurrent and a clinician dashboard for remote oversight. It’s designed to support physiological patterns associated with PTSD, including autonomic imbalance and inflammatory activation.
What’s included:
-
Smart‑textile electrodes that require no gels
-
A comfortable, mobile‑optimized wearable sleeve
-
Subsensory microcurrent protocols tailored to individual needs
-
Motion and physiologic sensing for adherence insight
-
A clinician dashboard to monitor and adjust programs
-
Multi‑user capability for clinic and at‑home use
How the Technology Works
Smart textiles
Soft, flexible conductive fibers deliver microcurrent evenly and comfortably without sticky pads.
Subsensory microcurrent
Low‑level electrical current interacts with the body’s natural signaling pathways. Published microcurrent research suggests potential effects on mitochondrial ATP, inflammatory cytokines, and autonomic activity.
Physiologic sensing
Integrated sensors track movement and session adherence to inform personalization.
Clinician dashboard
Clinicians can oversee progress and adjust programs securely, enabling one‑to‑many supervision.
Real‑world mobility
Use at home, in the clinic, or on the move. Sessions can run while users work, rest, or travel.
Evidence From
Real Environments
Real-world human data from military, sports, and clinical settings.
We are advancing through an early‑evidence phase shaped by real operational needs. Field observations, pilot data, and clinical microcurrent research together inform the NeuroEmpathy approach.
NeuroEmpathy is seeking strategic partners and investment to accelerate evidence generation and support deployment across VA and non‑VA clinical settings.
Military field observations
In deployed environments, observational data indicate ~90% of soldiers showed meaningful improvement when autonomic and musculoskeletal microcurrent protocols were used together. Unit testimonial on file.
Sports performance
Anecdotal observations suggest microcurrent may support recovery timelines; citable results will be shared as studies complete.
Microcurrent neurofeedback
Select small studies report improvements on PTSD‑related measures with microcurrent‑based approaches. Upcoming studies are designed for external validation.
Why This Matters
PTSD affects the body as well as the mind.
Autonomic imbalance and inflammation can slow recovery and increase symptom burden.
NeuroEmpathy focuses on these biological patterns with a wearable, personalized approach designed for daily life.
By combining microcurrent, smart textiles, and remote clinical oversight, the goal is accessible, scalable PTSD support.
Who we serve:
-
Veterans and active‑duty military
-
First responders
-
Civilians with PTSD or trauma‑related stress injury
-
Mental health and behavioral health providers
-
Rehabilitation and performance environments
The platform is being prepared for clinical research to establish safety and efficacy.
Origin Story
During a period of intense operational demand, clinicians observed that musculoskeletal and stress‑related conditions often failed to improve until autonomic imbalance was addressed.
Adding autonomic‑focused microcurrent protocols accelerated recovery. This insight, combined with advances in smart textiles, led to a wearable system purpose‑built for PTSD‑related recovery.
%20neu.jpg)
Current Phase
NeuroEmpathy is advancing toward U.S.‑based clinical trials in PTSD. Smart‑textile prototypes have been evaluated in military and sports settings, and the platform is progressing through design‑for‑manufacturing and regulatory preparation.
Organizations interested in research partnerships or clinical implementation are invited to connect.
The Team
Aviv Lubell, Chief Commercial Officer
Specialist in medical device commercialization, hospital procurement pathways, and pilot-to-revenue conversion.
Christopher St-Amour, Chief Operating Officer
Operations and strategy leader overseeing product execution, partnerships, and cross-functional program management.
Moshe Lebowitz, Founder
Founder and CEO of Healables Digital Health and creator of NeuroEmpathy; a wartime veteran and brain tumor survivor specializing in bioelectric medicine, certified in craniosacral therapy and Chinese medicine.
COL George H. Lowell (Ret.), Scientific Advisor
Former Chief Scientific Officer for BioDefense at GSK. Brings experience in regulatory strategy, military medicine, and biodefense innovation.
Mimi Dickman, PTSD Trauma Therapy Psychologist
PTSD-focused clinician trained in Somatic Experiencing under Peter Levine, integrating body‑based trauma resolution with evidence‑informed psychotherapy for complex and combat‑related stress